Current Cancer Drug Targets
Title: Editorial [Hot topic: Special Edition Myeloproliferative Neoplasia – Disease Pathogenesis and Treatment Options (Guest Editors: D. Wolf and H. Rumpold)]
Volume: 11 Issue: 1
Author(s): Dominik Wolf and H. Rumpold
Affiliation:
Export Options
About this article
Cite this article as:
Wolf Dominik and Rumpold H., Editorial [Hot topic: Special Edition Myeloproliferative Neoplasia – Disease Pathogenesis and Treatment Options (Guest Editors: D. Wolf and H. Rumpold)], Current Cancer Drug Targets 2011; 11 (1) . https://dx.doi.org/10.2174/156800911793743646
DOI https://dx.doi.org/10.2174/156800911793743646 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Persistent P21Cip1 Induction Mediates G1 Cell Cycle Arrest by Methylseleninic Acid in DU145 Prostate Cancer Cells
Current Cancer Drug Targets Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety
Recent Patents on Anti-Cancer Drug Discovery SCAN-Toolbox: Structural COBRA Add-oN (SCAN) for Analysing Large Metabolic Networks
Current Bioinformatics P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Drug Metabolism Letters Significance of Metallothionein Expression in Liver Disease
Current Pharmaceutical Biotechnology Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer
Current Drug Targets Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles
Current Pharmaceutical Design Metabolomics for Personalized Nutrition Research and Clinical Applications
Current Pharmacogenomics and Personalized Medicine A Comparison of the Inhibitory Effects of Anti-Cancer Drugs on Thioredoxin Reductase and Glutathione S-Transferase in Rat Liver
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Cancer Therapy Reviews Aurora-B Kinase Inhibitors for Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry Ovulation Inducing Agents and Cancer Risk: Review of Literature
Current Drug Safety Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene
Current Drug Metabolism Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Pharmacogenetics and Pharmagenomics, Trends in Normal and Pathological Aging Studies: Focus on p53
Current Pharmaceutical Design Synthesis, Structure-Activity Relationships and Antagonistic Effects in Human MCF-7 Breast Cancer Cells of Flexible Estrogen Receptor Modulators
Medicinal Chemistry Cellular Physiology of Mismatch Repair
Current Pharmaceutical Design Anticancer Compounds as Leishmanicidal Drugs: Challenges in Chemotherapy and Future Perspectives
Current Medicinal Chemistry Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets Possibilities of Non-Viral Gene Transfer to Improve Cutaneous Wound Healing
Current Gene Therapy